Drug Discovery World

MAY 4, 2023

Adaptyv Bio, a Swiss/US technology company that develops infrastructure and tools for protein designers to engineer better proteins, has built a protein engineering foundry that it says will “pave the way” for protein designers to develop new medicines, novel enzymes and sustainable materials.

Engineer 52

Engineer Protein Life Science Medicine 52

Bio Pharma Dive

MARCH 30, 2021

Two drugs developed by Wave Life Sciences didn't appear to have an effect on disease-causing proteins, another setback for Huntington's research after disappointing results last week from Roche and Ionis.

Life Science 294

Life Science Drugs Trials Protein 294

XTalks

DECEMBER 22, 2021

If the past year is anything to go by, then 2022 will also be a year marked by continued innovations in the life sciences. Here is a look at some life science trends to expect in the coming year, including key themes and topics in the pharmaceutical, biotechnology and medical device industries to keep an eye out for in 2022.

Life Science 98

Life Science RNA Vaccination Vaccine 98

Drug Discovery World

FEBRUARY 24, 2023

It is called, Harnessing the power of data science and AI in life sciences. Abbey Vangeloff is the Director of Business Development, Life Sciences, at Yahara Software. DDW’s Megan Thomas caught up with Vangeloff to learn why AI and data science are so important for the future of the sector.

Life Science 52

Life Science Business Development Protein Development 52

Drug Discovery World

DECEMBER 20, 2022

A project creating a new class of therapeutic proteins to modulate cell signalling has been accepted into the BioInnovation Institute (BII) Bio Studio programme. BII is an international enterprise foundation with a non-profit objective of incubating and accelerating world-class life science research. Macromolecular structures.

Protein 52

Protein Life Science Antibody Business Development 52

XTalks

FEBRUARY 29, 2024

Dual-function fusion proteins represent a cutting-edge approach in biopharmaceutical research, offering a promising avenue for the development of novel therapeutics in the treatment of complex diseases such as cancer and autoimmune disorders. At the helm of this venture is Dr. Taylor H. How is your lead program differentiated?

Protein 94

Protein Development Clinical Trials Clinical Trials 94

Drug Discovery World

FEBRUARY 23, 2023

This is episode four, How machine learning and lab automation are changing the future of protein therapeutics. The post Podcast: ML and lab automation are changing protein therapeutics appeared first on Drug Discovery World (DDW). Only one entry per person. Selfie must include supplement front cover to qualify.

Protein 52

Protein Life Science Development Drugs 52

Medical Xpress

MARCH 1, 2023

Cholesterol tremendously increases the toxicity of a peptide implicated in Alzheimer's progression, according to research by scientists in the Department of Biochemistry and Biophysics in Texas A&M's College of Agriculture and Life Sciences.

Protein 91

Protein Life Science Scientist Research 91

pharmaphorum

NOVEMBER 7, 2022

1910 Genetics, a biotechnology company integrating artificial intelligence (AI), computation and biological automation to accelerate the design of small molecule and protein therapeutics, has appointed Patrick Genestin as chief business officer. .” Patrick Genestin, 1910 Genetics .

Life Science 105

Life Science Genetics Business Development Marketing 105

XTalks

JULY 20, 2022

It is also the first protein-based COVID-19 vaccine to be authorized in the country. Read the full articles here: Novavax Vaccine Becomes First FDA-Authorized Protein Vaccine for COVID-19. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 52

Life Science Vaccination Vaccine Drugs 52

XTalks

NOVEMBER 30, 2022

The approval was awarded to CSL Behring’s Hemgenix, a single-dose gene therapy that delivers a working copy of the gene that codes for the Factor IX protein that is deficient, or made in insufficient amounts, in patients with Hemophilia B. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Gene Therapy 52

Gene Therapy Life Science Gene FDA Approval 52

XTalks

MAY 10, 2023

The treatment, an antisense oligonucleotide developed by Biogen, targets abnormal proteins arising from SOD1 mutations, which are associated with the development of ALS in some patients. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

Life Science 52

Life Science Vaccination Vaccine FDA Approval 52

XTalks

DECEMBER 17, 2021

Xtalks is taking a look at some of the major stories and innovations of the year in the life sciences, many of which were driven by new, emerging and improved technologies. The year 2021 was all about continuing innovations in the life sciences. Life Science Innovations: Malaria and Influenza Vaccines.

Life Science 98

Life Science Vaccination Vaccine Trials 98

XTalks

JANUARY 19, 2022

The research shows that exercise increases levels of synaptic proteins in the brain involved in maintaining and strengthening neuronal connections. The researchers also found these proteins could be protective even in people with dementia and other neurodegenerative diseases like Alzheimer’s.

Life Science 52

Life Science Protein Development Research 52

XTalks

MARCH 31, 2023

By growing high quality crystal structures of protein-based therapeutics under microgravity, researchers can gain better insights into their complex structures and stability. The proteins will be analyzed back on Earth using techniques such as X-ray diffraction and compared with crystals from the same biologics grown on Earth.

Protein 97

Protein Research Development Manufacturing 97

Drug Discovery World

DECEMBER 12, 2022

GenScript Biotech, a provider of life-science research tools and services, is partnering with Allozymes, a Singapore-based biotech startup, with aims to accelerate the enzyme discovery and development process. .

Protein 52

Protein Life Science Engineer Development 52

XTalks

JANUARY 5, 2021

The test identifies SARS-CoV-2 protein fragments from nasal swab samples. AI is expected to make significant strides in the life science and healthcare sectors in 2021. Reliable and rapid testing will continue to be a need next year as effective tracing and testing will be key to helping resolve the pandemic.

Life Science 98

Life Science Clinical Trials Clinical Trials Trials 98

Drug Discovery World

FEBRUARY 23, 2023

This is episode four, How machine learning and lab automation are changing the future of protein therapeutics. The post DDW Events podcast: How machine learning and lab automation are changing the future of protein therapeutics appeared first on Drug Discovery World (DDW). Selfie must include supplement front cover to qualify.

Protein 52

Protein Life Science Development Drugs 52

XTalks

DECEMBER 24, 2020

The pandemic propelled the life science and healthcare sectors onto center stage, and they rose to the occasion against the most unprecedented health challenge in recent times. While COVID-19 has undoubtedly been the biggest story in the life science industry in 2020, it was a busy and positive year in many other areas.

Life Science 111

Life Science Vaccination Vaccine Gene 111

Drug Discovery World

FEBRUARY 23, 2023

Kristen Hopson , Vice President of Preclinical Discovery and Development at Generate Biomedicines, and Yup Liu , Associate Director, HTS at Generate Biomedicines, reflect on the impact of AI, ML cloud computing, and advances in laboratory automation and high-throughput screening (HTS) on life science research.

Protein 52

Protein Life Science Bioassay Development 52

XTalks

JULY 19, 2022

The two-dose protein-based, adjuvanted vaccine has been authorized for use in adults 18 years of age and older for the prevention of COVID-19 caused by SARS-CoV-2. Nevertheless, 77 percent of those polled said that even if a protein-based COVID shot were authorized in the US, they still would not get it.

Vaccination 94

Vaccination Vaccine Protein Clinical Trials 94

BioPharma Reporter

MARCH 22, 2022

Fujifilm Irvine Scientific, Inc, has announced the acquisition of Shenandoah Biotechnology, a company supplying recombinant proteins to the drug discovery, life science research, and cell and gene therapy markets.

Gene Therapy 98

Gene Therapy Life Science Protein Gene 98

Drug Discovery World

MARCH 22, 2024

The site will provide Recursion and Valence Labs, the company’s artificial intelligence (AI) research engine, with access to European talent and a life science ecosystem from which to work. Professor Bronstein works in geometric deep learning, graph neural networks, and protein design.

Life Science 64

Life Science Drugs Engineer Protein 64

XTalks

JUNE 20, 2022

Hereditary ATTR has an autosomal dominant pattern of inheritance and is caused by point mutations in the transthyretin ( TTR ) gene that codes for the transthyretin transport protein found in the plasma and cerebrospinal fluid.

FDA Approval 98

FDA Approval Protein Genetics RNA 98

XTalks

MAY 7, 2021

As Novavax awaits emergency use authorization (EUA) from the US Food and Drug Administration (FDA) for its protein-based COVID-19 vaccine NVX-CoV2373, the company shared new data this week on the vaccine’s efficacy against the South African B.1.351 1.351 variant.

Protein 97

Protein Vaccination Vaccine Trials 97

Pharmaceutical Technology

OCTOBER 20, 2022

The funding round saw participation from current investors of the company, Advent Life Sciences and Belinda Termeer. This drug is an allosteric protein translation modulator that acts on eIF4E. According to preclinical research, PIC compounds modulate protein translation but do not hinder the process.

Development 130

Development Drugs Protein Life Science 130

Drug Discovery World

OCTOBER 12, 2023

However, in life science, labeled data are often in short supply. BioMap’s Chief Technology Officer, Le Song, said: “We have built what is essentially a biological map of proteins using data sets from public and private sources to inform our foundational models.

Development 52

Development Protein Life Science Pharma Companies 52

Scienmag

FEBRUARY 5, 2021

Membrane-localized phage proteins may also help revitalize, enhance existing antibiotics A study from the Center for Phage Technology, part of Texas A&M’s College of Agriculture and Life Sciences and Texas A&M AgriLife Research, shows how the “hidden” genes in bacteriophages — types of viruses that infect and destroy (..)

Gene 74

Gene Bacteria Life Science Development 74

Drug Discovery World

MAY 13, 2024

MA: Regarding vaccine development specifically, and the role my team plays in the development of cryogenic electron microscopy (cryo-EM) technology, we see the study and dissemination of virus structures, and the proteins that comprise them, as vital to vaccine design. For example, there are global monitoring efforts for new Covid strains.

Vaccination 59

Vaccination Vaccine Protein Antibody 59

Drug Discovery World

FEBRUARY 24, 2023

It is called, Harnessing the power of data science and AI in life sciences. Abbey Vangeloff is the Director of Business Development, Life Sciences, at Yahara Software. DDW’s Megan Thomas caught up with Vangeloff to learn why AI and data science are so important for the future of the sector.

Life Science 52

Life Science Business Development Protein Development 52

Drug Discovery World

FEBRUARY 25, 2023

To win, simply make your way to the SLAS Booth at 2621, pick up a copy of the official SLAS supplement published by DDW, and take a selfie with it.

Life Science 52

Life Science Protein Drugs 52

Scienmag

DECEMBER 22, 2020

Credit: Kanazawa University Nowadays nanotechnology allows to observe single proteins at work. Under atomic force microscopy (AFM), e.g., their surface can be rapidly scanned, and functional motions monitored, which is of great importance for applications in all fields of Life science.

Life Science 52

Life Science Protein Bioinformatics Engineer 52

Drug Discovery World

FEBRUARY 20, 2024

AI-driven solutions aim to enhance the speed, accuracy and efficiency of research and development processes within the life sciences industry.

Marketing 52

Marketing Drugs Life Science Genome 52

Pharmaceutical Technology

APRIL 18, 2023

Innovation S-curve for the pharmaceutical industry HIV peptides is a key innovation area in pharmaceuticals HIV peptides are fragments derived from HIV envelope gp160 protein, the HIV matrix/capsid proteins, and the HIV gag, pol and env gene products.

Protein 147

Protein Vaccination Vaccine Production 147

Drug Discovery World

MARCH 14, 2023

Teitur Trophics, a biotech company developing new treatments for patients suffering from neurodegenerative diseases, has complete a €28M Series A financing. The financing was co-led by Sunstone Life Science Ventures and Sound Bioventures, with participation from new investors, Industrifonden, Innovestor’s Life Science Fund and P53 Invest.

Life Science 52

Life Science Clinical Development Development Drugs 52

Drug Discovery World

APRIL 27, 2023

The report notes that the focus on science and pharma throughout the Covid-19 pandemic has resulted in the emergence of new locations as life science hubs and name checks Boston, Massachusetts and San Francisco, California as examples of centres with heightened investment appeal in the life sciences 1.

Life Science 52

Life Science Drugs Research Gene Splicing 52

XTalks

FEBRUARY 26, 2024

XTALKS WEBINAR: On-Demand Code-Level Claims Data: Driving Actionable Insights and Efficiencies Live and On-Demand: Wednesday, April 3, 2024, at 1pm EDT (5pm GMT/UK) Register for this free webinar to learn how code-level claims data is a crucial dataset to address various needs across the life sciences and medical device landscape.

Allergies 100

Allergies FDA Approval Drugs Protein 100